Pathogenetix Nabs $4M

Pathogenetix, a Woburn, MA-based company formerly named U.S. Genomics, has raised $4 million of an equity offering that could total $9.5 million, an SEC filing shows. Last November, the firm, which develops biodefense and diagnostic technologies, raised $900,000 of a debt-based round and $1.3 million in an equity financing—the latter of which was bumped up to $1.5 million a month later, according to SEC documents.

Trending on Xconomy

By posting a comment, you agree to our terms and conditions.

Comments are closed.